Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.

Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A, Arteaga CL
Cancer Res. 2009 69 (2): 475-82

PMID: 19147560 · PMCID: PMC2629389 · DOI:10.1158/0008-5472.CAN-08-2649

It has been proposed that cross talk between integrin and growth factor receptor signaling such as ErbB2 (HER2) is required for activation of downstream effectors and ErbB2-mediated mammary tumorigenesis. Here we show that transforming growth factor beta (TGF-beta) induced focal adhesion kinase (FAK)-dependent clustering of HER2 and integrins alpha(6), beta(1), and beta(4) in HER2-overexpressing mammary epithelial cells without altering the total and surface levels of HER2 receptors. This effect was mediated by ligand-induced epidermal growth factor receptor (EGFR) activation and the subsequent phosphorylation of Src and FAK. We have previously reported that TGF-beta up-regulates EGFR ligand shedding through a mechanism involving the phosphorylation of tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). Knockdown of TACE, FAK, or integrin alpha(6) by siRNA or inhibition of EGFR or Src by specific inhibitors abrogated TGF-beta-induced receptor clustering and signaling to phosphatidylinositol 3-kinase-Akt. Finally, inhibition of Src-FAK reversed TGF-beta-induced resistance to the therapeutic HER2 inhibitor trastuzumab in HER2-overexpressing breast cancer cells. Taken together, these data suggest that, by activating Src-FAK, TGF-beta integrates ErbB receptor and integrin signaling to induce cell migration and survival during breast cancer progression.

MeSH Terms (18)

Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Breast Neoplasms Cell Line, Tumor Cell Membrane Cytoskeleton Enzyme Activation ErbB Receptors Focal Adhesion Kinase 1 Humans Integrins Phosphatidylinositol 3-Kinases Proto-Oncogene Proteins c-akt Receptor, ErbB-2 Receptor Cross-Talk src-Family Kinases Transforming Growth Factor beta Trastuzumab

Connections (6)

This publication is referenced by other Labnodes entities: